The U.S. Department of Energy (DOE) has announced $134 million in funding to accelerate the development of fusion energy technologies and strengthen partnerships between the private sector, national laboratories, and universities.
New research shows that exposure to PFAS chemicals may increase the risk of type 2 diabetes by disrupting metabolism and affecting blood sugar regulation.
King’s College London researchers warn of elevated risk from hospital-only medications and illicit drug use within healthcare settings, linking patient and healthcare worker fatalities to gaps in prescribing, discharge planning, and policy.
The European Commission has expanded its support for clean technology development by awarding grant agreements to six additional projects under the Innovation Fund 2023 general call for Net-Zero Technologies (IF23 Call).
The UK Government has awarded £63 million to 17 domestic clean aviation fuel projects, supporting around 1,400 jobs and reinforcing Britain’s ambition to become a global leader in sustainable aviation.
The U.S. Department of Energy (DOE) has revealed its next steps forward in revitalising America's nuclear energy sector with the launch of a new pilot program aimed at building advanced somatic nuclear fuel production lines.
UCL and UCLH launch the Win‑Glio trial led by Dr Paul Mulholland, offering ipilimumab immunotherapy to newly diagnosed glioblastoma patients ahead of standard treatment.
With satellite navigation becoming increasingly crucial to global infrastructure, there is a growing threat of spoofing, which involves the deliberate broadcasting of false navigation signals, but OSNMA may be the answer to this problem.
As regional leaders gain more autonomy through devolution, it is crucial for them to have access to accurate and timely financial data to make informed decisions. Matt Bland, Director at Vision ERP, emphasises the importance of modern finance systems in supporting decision-making and ultimately delivering visible and trustworthy results for communities.
The United Kingdom Atomic Energy Authority (UKAEA) has taken the next step towards the future of fusion energy by commissioning two advanced additive manufacturing machines.
A breakthrough treatment for severe hay fever caused by birch pollen will soon be available on the NHS, as NICE recommends the first daily immunotherapy tablet for patients who don’t respond to standard therapies.
HC Legionella Ltd investigated temperature issues in hot water cylinders for a healthcare site, where temperatures were in a range conducive to bacterial growth; here, Authorising Engineer, Claire Jackson, explains how the issue was resolved.
The UK has approved its first-ever needle-free adrenaline treatment for severe allergic reactions, marking a major development in how anaphylaxis could be managed in emergencies.
The UK Government has unveiled an enhanced support plan for people with ME/CFS, including NHS staff training, public awareness campaigns, and up to £200,000 in grants per research project.
